WASHINGTON (MedPage Today) -- Researchers described early progress in the development of new agents that target difficult-to-treat Gram-negative resistant bacteria, including one drug already in early human testing that uses a "Trojan Horse" concept. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment